Researchers at McMaster University have developed a new generative artificial intelligence (AI) model capable of drastically speeding up drug discovery - and, in early tests, it has already designed a brand-new antibiotic.

The discovery is a demonstration of how AI could dramatically improve the slow and costly search for new antimicrobial medicines, as bacteria and other microbes continue to evolve resistance to our current suite of drugs.

Oregon Health & Science University researchers have developed a first-of-its-kind method to predict cancer patient survival using advanced molecular data from individual cells.

Survival analysis is central to clinical oncology. Modern cancer studies can now measure gene activity in single cells from a patient’s tumor and link this information to how long patients live.

There may be some truth to the saying "the eyes are the window to the soul." Age-related changes are reflected in the retina, the light-sensitive tissue at the back of the eye. Recent research shows that a photo of the retina may also reveal potential risks for major diseases like diabetes. A research group led by Professor Toru Nakazawa at the Tohoku University Graduate School of Medicine has developed an artificial intelligence (AI) model that estimates "retinal age,"

Artificial intelligence (AI) is transforming breast cancer care by improving diagnosis, treatment planning, and drug development. AI technologies, particularly deep learning (DL) and machine learning (ML), are enhancing screening efficiency, reducing errors, and aiding in personalized treatment decisions. With the ability to analyze large datasets, AI is revolutionizing how breast cancer is detected and managed, leading to better outcomes for patients.

University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines.

UVA’s Nikolay V. Dokholyan, PhD, and colleagues have developed a suite of artificial intelligence-powered tools, called YuelDesign, YuelPocket and YuelBond, that work together to transform how new drugs are created.

AI models can generate more complete summaries of complex cancer pathology reports than physicians, according to a new Northwestern Medicine study that tested six models developed by Meta, Google, DeepSeek and Mistral AI.

The study was published in JCO Clinical Cancer Informatics, a journal from the American Society of Clinical Oncology.

A new study using an advanced “digital twin” artificial intelligence model has found that factors such as loneliness, insomnia and poor mental health substantially raise a person’s future risk of developing type 2 diabetes.

The research, led by Anglia Ruskin University (ARU) in collaboration with Cranfield University, the University of Portsmouth, and Intelligent Omics Ltd, and published in Frontiers in Digital Health, used lifestyle and health data from 19,774 UK adults in the UK Biobank, tracked for up to 17 years.